Recent Clinical Trial Updates Shift DLBCL Treatment Paradigm

Gilles Salles, MD, PhD, expands on how data from recent clinical trials have helped shift the treatment paradigm for patients with diffuse large B-cell lymphoma.

Related Keywords

New York ,United States ,Stevena Greenberg ,Gillesa Salles , ,Lymphoma Service ,Memorial Sloan Kettering Cancer Center ,Second Line ,Gilles Salles ,D ,Phd ,Dlbcl ,Cfs ,Non Hodgkin Lymphoma ,Diffuse Largeb Cell Lymphoma ,